Your search returned 1978 results.

Results
	121.	Initiating PCSK9 Inhibition in Hospital for ACS: We Can, But Does That Mean We Should? [electronic resource] by Schwartz, Gregory G Chaitman, Bernard R Producer: 20200506 In: Journal of the American College of Cardiology vol. 74 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	122.	New hope for hyperlipidemia management: Inclisiran. [electronic resource] by Bandyopadhyay, Dhrubajyoti Hajra, Adrija Ashish, Kumar Qureshi, Arshna Ball, Somedeb Producer: 20190415 In: Journal of cardiology vol. 71 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	123.	PCSK9 inhibition for autosomal recessive hypercholesterolemia. [electronic resource] by Chemello, Kévin Martín, Cesar Lambert, Gilles Producer: 20191230 In: Atherosclerosis vol. 284 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	124.	A Healthy Family of Familial Hypobetalipoproteinemia Caused by a Protein-truncating Variant in the PCSK9 Gene. [electronic resource] by Tada, Hayato Okada, Hirofumi Nomura, Akihiro Nohara, Atsushi Takamura, Masayuki Kawashiri, Masa-Aki Producer: 20200609 In: Internal medicine (Tokyo, Japan) vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	125.	PCSK9 inhibition in statin-intolerant HeFH patients: What's new? [electronic resource] by Casula, Manuela Pirillo, Angela Norata, Giuseppe Danilo Catapano, Alberico Luigi Producer: 20180131 In: European journal of preventive cardiology vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	126.	Lipids: Very low achieved LDL-cholesterol levels improve cardiovascular outcomes. [electronic resource] by Huynh, Karina Producer: 20190725 In: Nature reviews. Cardiology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	127.	Realizing Value With Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Are We Closer to Finding the Sweet Spot? [electronic resource] by Blumenthal, Roger S Nasir, Khurram Martin, Seth S Producer: 20190910 In: Circulation vol. 138 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	128.	Cellular and secreted pro-protein convertase subtilisin/kexin type 9 catalytic activity in hepatocytes. [electronic resource] by Kourimate, Sanae Chétiveaux, Maud Jarnoux, Anne Laure Lalanne, Florent Costet, Philippe Producer: 20091202 In: Atherosclerosis vol. 206 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	129.	Dyslipidaemia: Anti-PCSK9 vaccines to halt atherosclerosis. [electronic resource] by Ummarino, Dario Producer: 20190806 In: Nature reviews. Cardiology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	130.	Response to Comment on de Carvalho et al. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364-367. [electronic resource] by de Carvalho, Luiz Sérgio F Campos, Alessandra M Sposito, Andrei C Producer: 20180521 In: Diabetes care vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	131.	[Renal Dyslipidemia]. [electronic resource] by Kimura, Hideki Producer: 20190422 In: Rinsho byori. The Japanese journal of clinical pathology vol. 64 Availability: No items available. Save to lists Add to cart (remove)
	132.	Modulation of cardiovascular risk factors. [electronic resource] by Bhatnagar, Deepak Shiraz, Ahmad Producer: 20191003 In: Current opinion in lipidology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	133.	How much further do we need to decrease LDL cholesterol levels in heterozygous familial hypercholesterolemia? [electronic resource] by Harada-Shiba, Mariko Producer: 20191230 In: Atherosclerosis vol. 284 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	134.	Hypercholesterolemia Among Premature Infarcts: Time to Start the Clock of Familial Hypercholesterolemia Assessment. [electronic resource] by Hovingh, G Kees Reeskamp, Laurens F Ray, Kausik K Producer: 20200325 In: Journal of the American College of Cardiology vol. 73 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	135.	PCSK9 is Increased in Cerebrospinal Fluid of Individuals With Alcohol Use Disorder. [electronic resource] by Lee, Ji Soo Rosoff, Daniel Luo, Audrey Longley, Martha Phillips, Monte Charlet, Katrin Muench, Christine Jung, Jeesun Lohoff, Falk W Producer: 20200903 In: Alcoholism, clinical and experimental research vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	136.	Having excess levels of PCSK9 is not sufficient to induce complex formation between PCSK9 and the LDL receptor. [electronic resource] by Wooten, Catherine J Adcock, Audrey F Agina-Obu, DaTonye I Lopez, Dayami Producer: 20140421 In: Archives of biochemistry and biophysics vol. 545 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	137.	Insights into PCSK9, low-density lipoprotein receptor, and low-density lipoprotein cholesterol metabolism: of mice and man. [electronic resource] by Stein, Evan A Raal, Frederick J Producer: 20131211 In: Circulation vol. 127 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	138.	Association between plasma proprotein convertase subtisilin/kexin type 9 concentration and coronary artery calcification. [electronic resource] by Zhao, Xi Zhang, Hui-Wen Li, Sha Zhang, Yan Xu, Rui-Xia Zhu, Cheng-Gang Wu, Na-Qiong Guo, Yuan-Lin Qing, Ping Li, Xiao-Lin Liu, Geng Dong, Qian Sun, Jing Li, Jian-Jun Producer: 20180730 In: Annals of clinical biochemistry vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	139.	Proprotein convertase subtilisin/kexin type 9 in patients with systemic sclerosis. [electronic resource] by Ferraz-Amaro, Ivan Delgado-Frías, Esmeralda Hernández-Hernández, Vanesa Sánchez-Pérez, Hiurma de Armas-Rillo, Laura García-Dopico, José A Díaz-González, Federico Producer: 20200917 In: Clinical and experimental rheumatology vol. 38 Suppl 125 Availability: No items available. Save to lists Add to cart (remove)
	140.	Dyslipidaemia: Promising results with siRNA against PCSK9. [electronic resource] by Fernández-Ruiz, Irene Producer: 20190712 In: Nature reviews. Cardiology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1978 results.